Ozempic maker Novo Nordisk misses profit estimates as it builds out capacity

[ad_1]


Novo Nordisk, Europe’s largest company by market cap thanks to its wildly popular weight-loss drugs, managed just a small increase in second-quarter profits as it builds out the capacity to make the products.

[ad_2]

Source link